# C_2021324EN.01001601.xml

| 12.8.2021 | EN | Official Journal of the European Union | C 324/16 |
| --- | --- | --- | --- |

12.8.2021

EN

Official Journal of the European Union

C 324/16

---

Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the second half of 2020

(2021/C 324/10)

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July – 31 December 2020, at their meeting on 19 March 2021:

| Annex I | List of new marketing authorisations |
| --- | --- |

Annex I

| Annex II | List of renewed marketing authorisations |
| --- | --- |

Annex II

| Annex III | List of extended marketing authorisations |
| --- | --- |

Annex III

| Annex IV | List of withdrawn marketing authorisations |
| --- | --- |

Annex IV

| Annex V | List of suspended marketing authorisations |
| --- | --- |

Annex V

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July – 31 December 2020:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/20/1476 | Adakveo | Iceland | 6.11.2020 |
| EU/1/20/1476 | Adakveo | Norway | 5.11.2020 |
| EU/1/20/1458 | Apixaban Accord | Iceland | 10.8.2020 |
| EU/1/20/1458 | Apixaban Accord | Liechtenstein | 31.8.2020 |
| EU/1/20/1458 | Apixaban Accord | Norway | 10.8.2020 |
| EU/1/20/1469 | Arikayce liposomal | Norway | 2.11.2020 |
| EU/1/20/1469 | Arikayce liposomal | Iceland | 5.11.2020 |
| EU/1/20/1475 | Arsenic trioxide medac | Iceland | 14.10.2020 |
| EU/1/20/1475 | Arsenic trioxide medac | Norway | 29.9.2020 |
| EU/1/20/1454 | Aybintio | Iceland | 25.8.2020 |
| EU/120/1454 | Aybintio | Liechtenstein | 31.8.2020 |
| EU/1/20/1454 | Aybintio | Norway | 25.8.2020 |
| EU/1/20/1473 | AYVAKYT | Iceland | 14.10.2020 |
| EU/1/20/1473 | Ayvakyt | Norway | 29.9.2020 |
| EU/1/17/1214 | Bavencio | Liechtenstein | 31.8.2020 |
| EU/1/20/1474 | Blenrep | Iceland | 14.9.2020 |
| EU/1/20/1474 | Blenrep | Liechtenstein | 31.8.2020 |
| EU/1/20/1474 | Blenrep | Norway | 2.9.2020 |
| EU/1/19/1403 | Budesonid/Formoterol Teva Pharma B.V. | Liechtenstein | 31.8.2020 |
| EU/1/20/1448 | Cabazitaxel Accord | Iceland | 3.9.2020 |
| EU/1/20/1448 | Cabazitaxel Accord | Norway | 28.10.2020 |
| EU/1/20/1479 | Calquence | Iceland | 10.11.2020 |
| EU/1/20/1479 | Calquence | Norway | 11.11.2020 |
| EU/2/20/264 | Circomax Myco | Norway | 16.12.2020 |
| EU/1/20/1528 | Comirnaty | Iceland | 21.12.2020 |
| EU/1/20/1528 | Comirnaty | Norway | 21.12.2020 |
| EU/1/20/1451 | Daurismo | Iceland | 20.7.2020 |
| EU/1/20/1451 | Daurismo | Norway | 3.7.2020 |
| EU/1/20/1438 | Enerzair Breezhaler | Iceland | 21.7.2020 |
| EU/1/20/1438 | Enezair Breezhaler | Norway | 14.7.2020 |
| EU/2/20/262 | Enteroporc Coli AC | Norway | 16.12.2020 |
| EU/1/20/1472 | Equidacent | Iceland | 14.10.2020 |
| EU/1/20/1472 | Equidacent | Norway | 29.9.2020 |
| EU/1/20/1489 | Exparel liposomal | Iceland | 3.12.2020 |
| EU/1/20/1489 | Exparel liposomal | Norway | 24.11.2020 |
| EU/1/20/1477 | Fampridine Accord | Iceland | 15.10.2020 |
| EU/1/20/1477 | Fampridine Accord | Norway | 1.10.2020 |
| EU/1/20/1450 | Fingolimod Accord | Iceland | 20.7.2020 |
| EU/1/20/1450 | Fingolimod Accord | Norway | 13.7.2020 |
| EU/1/20/1465 | Gencebok | Iceland | 25.8.2020 |
| EU/1/20/1465 | Gencebok | Liechtenstein | 31.8.2020 |
| EU/1/20/1465 | Gencebok | Norway | 2.9.2020 |
| EU/1/20/1446 | Hepcludex | Iceland | 12.8.2020 |
| EU/1/20/1446 | Hepcludex | Liechtenstein | 31.8.2020 |
| EU/1/20/1446 | Hepcludex | Norway | 10.8.2020 |
| EU/1/20/1471 | Idefirix | Iceland | 2.9.2020 |
| EU/1/20/1471 | Idefirix | Liechtenstein | 31.8.2020 |
| EU/1/20/1471 | Idefirix | Norway | 8.9.2020 |
| EU/2/20/258 | Increxxa | Iceland | 21.9.2020 |
| EU/2/20/256 | Innovax-ND-ILT | Iceland | 16.10.2020 |
| EU/1/20/1447 | Insulin Aspart Sanofi | Iceland | 20.7.2020 |
| EU/1/20/144 | Insulin aspart Sanofi | Norway | 3.7.2020 |
| EU/1/20/1480 | Jyseleca | Iceland | 14.10.2020 |
| EU/1/20/1480 | Jyseleca | Norway | 30.9.2020 |
| EU/1/20/1468 | Kaftrio | Iceland | 25.8.2020 |
| EU/1/20/1468 | Kaftrio | Liechtenstein | 31.8.2020 |
| EU/1/20/1468 | Kaftrio | Norway | 3.9.2020 |
| EU/1/20/1494 | Leqvio | Norway | 15.12.2020 |
| EU/2/20/261 | Librela | Iceland | 13.11.2020 |
| EU/1/20/1462 | Livogiva | Iceland | 2.9.2020 |
| EU/1/20/1462 | Livogiva | Liechtenstein | 31.8.2020 |
| EU/1/20/1462 | Livogiva | Norway | 7.9.2020 |
| EU/1/20/1483 | MenQuadfi | Iceland | 2.12.2020 |
| EU/1/20/1483 | MenQuadfi | Norway | 30.11.2020 |
| EU/1/20/1470 | Methylthioninium chloride Cosmo | Iceland | 27.8.2020 |
| EU/1/20/1470 | Methylthioninium chloride Cosmo | Norway | 3.9.2020 |
| EU/2/20/259 | Mhyosphere PCV ID | Iceland | 14.10.2020 |
| EU/2/19/247 | Mirataz | Norway | 11.8.2020 |
| EU/1/20/1445 | Mvabea | Iceland | 21.7.2020 |
| EU/1/20/1445 | Mvabea | Norway | 13.7.2020 |
| EU/2/20/265 | Nobivac DP PLUS | Norway | 17.12.2020 |
| EU/1/20/1424 | Nustendi | Liechtenstein | 31.8.2020 |
| EU/1/20/1486 | Nyvepria | Iceland | 3.12.2020 |
| EU/1/20/1486 | Nyvepria | Norway | 24.11.2020 |
| EU/1/20/1485 | Obiltoxaximab SFL | Iceland | 8.12.2020 |
| EU/1/20/1485 | Obiltoxaximab SFL | Norway | 24.11.2020 |
| EU/2/20/260 | OvuGel | Iceland | 8.12.2020 |
| EU/1/20/1496 | Oxlumo | Iceland | 2.12.2020 |
| EU/1/20/1496 | Oxlumo | Norway | 24.11.2020 |
| EU/1/20/1487 | PHELINUN | Iceland | 3.12.2020 |
| EU/1/20/1487 | PHELINUN | Norway | 2.12.2020 |
| EU/1/20/1497 | Phesgo | Norway | 23.12.2020 |
| EU/1/20/1455 | Piqray | Iceland | 11.8.2020 |
| EU/1/20/1455 | Piqray | Liechtenstein | 31.8.2020 |
| EU/1/20/1455 | Piqray | Norway | 10.8.2020 |
| EU/1/20/1437 | Pretomanid FGK | Iceland | 12.8.2020 |
| EU/1/20/1437 | Pretomanid FGK | Liechtenstein | 31.8.2020 |
| EU/1/20/1437 | Pretomanid FGK | Norway | 10.8.2020 |
| EU/2/20/254 | Prevexxion RN | Iceland | 10.8.2020 |
| EU/2/20/254 | Prevexxion RN | Norway | 10.8.2020 |
| EU/2/20/255 | Prevexxion RN+HVT+IBD | Iceland | 27.7.2020 |
| EU/2/20/255 | Prevexxion RN+HVT+IBD | Liechtenstein | 31.8.2020 |
| EU/1/20/1463 | Qutavina | Iceland | 2.9.2020 |
| EU/1/20/1463 | Qutavina | Liechtenstein | 31.8.2020 |
| EU/1/20/1463 | Qutavina | Norway | 7.9.2020 |
| EU/1/20/1452 | Reblozyl | Iceland | 20.7.2020 |
| EU/1/20/1452 | Reblozyl | Norway | 3.7.2020 |
| EU/2/20/263 | Rexxolide | Norway | 16.12.2020 |
| EU/1/20/1488 | Rivaroxaban Accord | Iceland | 1.12.2020 |
| EU/1/20/1488 | Rivaroxaban Accord | Norway | 2.12.2020 |
| EU/1/20/1460 | Rozlytrek | Iceland | 12.8.2020 |
| EU/1/20/1460 | Rozlytrek | Norway | 10.8.2020 |
| EU/1/20/1484 | Supemtek | Iceland | 1.12.2020 |
| EU/1/20/1484 | Supemtek | Norway | 24.11.2020 |
| EU/1/20/1492 | Tecartus | Norway | 30.12.2020 |
| EU/1/20/1498 | TRIXEO AEROSPHERE | Norway | 16.12.2020 |
| EU/2/20/257 | Tulinovet | Iceland | 21.9.2020 |
| EU/2/20/257 | Tulinovet | Norway | 8.12.2020 |
| EU/1/20/1459 | Veklury | Iceland | 3.7.2020 |
| EU1/20/1459 | Veklury | Liechtenstein | 31.8.2020 |
| EU/1/20/1459 | Veklury | Norway | 3.7.2020 |
| EU/1/20/1481 | Vocabria | Norway | 30.12.2020 |
| EU/1/20/1457 | Xenleta | Iceland | 11.8.2020 |
| EU/1/20/1457 | Xenleta | Liechtenstein | 31.8.2020 |
| EU/1/20/1457 | Xenleta | Norway | 10.8.2020 |
| EU/1/20/1444 | Zabdeno | Iceland | 21.7.2020 |
| EU/1/20/1444 | Zabdeno | Liechtenstein | 31.8.2020 |
| EU/1/20/1444 | Zabdeno | Norway | 14.7.2020 |
| EU/1/20/1456 | Zercepac | Iceland | 11.8.2020 |
| EU/1/20/1456 | Zercepac | Liechtenstein | 31.8.2020 |
| EU/1/20/1456 | Zercepac | Norway | 10.8.2020 |
| EU/1/20/1440 | Zimbus Breezhaler | Iceland | 21.7.2020 |
| EU/1/20/1440 | Zimbus Breezhaler | Liechtenstein | 31.8.2020 |
| EU/1/20/1440 | Zimbus Breezhaler | Norway | 13.7.2020 |
| EU/1/20/1478 | ZYNRELEF | Iceland | 16.10.2020 |
| EU/1/20/1478 | Zynrelef | Norway | 1.10.2020 |

EU-Number

Product

Country

Date of authorisation

EU/1/20/1476

Adakveo

Iceland

6.11.2020

EU/1/20/1476

Adakveo

Norway

5.11.2020

EU/1/20/1458

Apixaban Accord

Iceland

10.8.2020

EU/1/20/1458

Apixaban Accord

Liechtenstein

31.8.2020

EU/1/20/1458

Apixaban Accord

Norway

10.8.2020

EU/1/20/1469

Arikayce liposomal

Norway

2.11.2020

EU/1/20/1469

Arikayce liposomal

Iceland

5.11.2020

EU/1/20/1475

Arsenic trioxide medac

Iceland

14.10.2020

EU/1/20/1475

Arsenic trioxide medac

Norway

29.9.2020

EU/1/20/1454

Aybintio

Iceland

25.8.2020

EU/120/1454

Aybintio

Liechtenstein

31.8.2020

EU/1/20/1454

Aybintio

Norway

25.8.2020

EU/1/20/1473

AYVAKYT

Iceland

14.10.2020

EU/1/20/1473

Ayvakyt

Norway

29.9.2020

EU/1/17/1214

Bavencio

Liechtenstein

31.8.2020

EU/1/20/1474

Blenrep

Iceland

14.9.2020

EU/1/20/1474

Blenrep

Liechtenstein

31.8.2020

EU/1/20/1474

Blenrep

Norway

2.9.2020

EU/1/19/1403

Budesonid/Formoterol Teva Pharma B.V.

Liechtenstein

31.8.2020

EU/1/20/1448

Cabazitaxel Accord

Iceland

3.9.2020

EU/1/20/1448

Cabazitaxel Accord

Norway

28.10.2020

EU/1/20/1479

Calquence

Iceland

10.11.2020

EU/1/20/1479

Calquence

Norway

11.11.2020

EU/2/20/264

Circomax Myco

Norway

16.12.2020

EU/1/20/1528

Comirnaty

Iceland

21.12.2020

EU/1/20/1528

Comirnaty

Norway

21.12.2020

EU/1/20/1451

Daurismo

Iceland

20.7.2020

EU/1/20/1451

Daurismo

Norway

3.7.2020

EU/1/20/1438

Enerzair Breezhaler

Iceland

21.7.2020

EU/1/20/1438

Enezair Breezhaler

Norway

14.7.2020

EU/2/20/262

Enteroporc Coli AC

Norway

16.12.2020

EU/1/20/1472

Equidacent

Iceland

14.10.2020

EU/1/20/1472

Equidacent

Norway

29.9.2020

EU/1/20/1489

Exparel liposomal

Iceland

3.12.2020

EU/1/20/1489

Exparel liposomal

Norway

24.11.2020

EU/1/20/1477

Fampridine Accord

Iceland

15.10.2020

EU/1/20/1477

Fampridine Accord

Norway

1.10.2020

EU/1/20/1450

Fingolimod Accord

Iceland

20.7.2020

EU/1/20/1450

Fingolimod Accord

Norway

13.7.2020

EU/1/20/1465

Gencebok

Iceland

25.8.2020

EU/1/20/1465

Gencebok

Liechtenstein

31.8.2020

EU/1/20/1465

Gencebok

Norway

2.9.2020

EU/1/20/1446

Hepcludex

Iceland

12.8.2020

EU/1/20/1446

Hepcludex

Liechtenstein

31.8.2020

EU/1/20/1446

Hepcludex

Norway

10.8.2020

EU/1/20/1471

Idefirix

Iceland

2.9.2020

EU/1/20/1471

Idefirix

Liechtenstein

31.8.2020

EU/1/20/1471

Idefirix

Norway

8.9.2020

EU/2/20/258

Increxxa

Iceland

21.9.2020

EU/2/20/256

Innovax-ND-ILT

Iceland

16.10.2020

EU/1/20/1447

Insulin Aspart Sanofi

Iceland

20.7.2020

EU/1/20/144

Insulin aspart Sanofi

Norway

3.7.2020

EU/1/20/1480

Jyseleca

Iceland

14.10.2020

EU/1/20/1480

Jyseleca

Norway

30.9.2020

EU/1/20/1468

Kaftrio

Iceland

25.8.2020

EU/1/20/1468

Kaftrio

Liechtenstein

31.8.2020

EU/1/20/1468

Kaftrio

Norway

3.9.2020

EU/1/20/1494

Leqvio

Norway

15.12.2020

EU/2/20/261

Librela

Iceland

13.11.2020

EU/1/20/1462

Livogiva

Iceland

2.9.2020

EU/1/20/1462

Livogiva

Liechtenstein

31.8.2020

EU/1/20/1462

Livogiva

Norway

7.9.2020

EU/1/20/1483

MenQuadfi

Iceland

2.12.2020

EU/1/20/1483

MenQuadfi

Norway

30.11.2020

EU/1/20/1470

Methylthioninium chloride Cosmo

Iceland

27.8.2020

EU/1/20/1470

Methylthioninium chloride Cosmo

Norway

3.9.2020

EU/2/20/259

Mhyosphere PCV ID

Iceland

14.10.2020

EU/2/19/247

Mirataz

Norway

11.8.2020

EU/1/20/1445

Mvabea

Iceland

21.7.2020

EU/1/20/1445

Mvabea

Norway

13.7.2020

EU/2/20/265

Nobivac DP PLUS

Norway

17.12.2020

EU/1/20/1424

Nustendi

Liechtenstein

31.8.2020

EU/1/20/1486

Nyvepria

Iceland

3.12.2020

EU/1/20/1486

Nyvepria

Norway

24.11.2020

EU/1/20/1485

Obiltoxaximab SFL

Iceland

8.12.2020

EU/1/20/1485

Obiltoxaximab SFL

Norway

24.11.2020

EU/2/20/260

OvuGel

Iceland

8.12.2020

EU/1/20/1496

Oxlumo

Iceland

2.12.2020

EU/1/20/1496

Oxlumo

Norway

24.11.2020

EU/1/20/1487

PHELINUN

Iceland

3.12.2020

EU/1/20/1487

PHELINUN

Norway

2.12.2020

EU/1/20/1497

Phesgo

Norway

23.12.2020

EU/1/20/1455

Piqray

Iceland

11.8.2020

EU/1/20/1455

Piqray

Liechtenstein

31.8.2020

EU/1/20/1455

Piqray

Norway

10.8.2020

EU/1/20/1437

Pretomanid FGK

Iceland

12.8.2020

EU/1/20/1437

Pretomanid FGK

Liechtenstein

31.8.2020

EU/1/20/1437

Pretomanid FGK

Norway

10.8.2020

EU/2/20/254

Prevexxion RN

Iceland

10.8.2020

EU/2/20/254

Prevexxion RN

Norway

10.8.2020

EU/2/20/255

Prevexxion RN+HVT+IBD

Iceland

27.7.2020

EU/2/20/255

Prevexxion RN+HVT+IBD

Liechtenstein

31.8.2020

EU/1/20/1463

Qutavina

Iceland

2.9.2020

EU/1/20/1463

Qutavina

Liechtenstein

31.8.2020

EU/1/20/1463

Qutavina

Norway

7.9.2020

EU/1/20/1452

Reblozyl

Iceland

20.7.2020

EU/1/20/1452

Reblozyl

Norway

3.7.2020

EU/2/20/263

Rexxolide

Norway

16.12.2020

EU/1/20/1488

Rivaroxaban Accord

Iceland

1.12.2020

EU/1/20/1488

Rivaroxaban Accord

Norway

2.12.2020

EU/1/20/1460

Rozlytrek

Iceland

12.8.2020

EU/1/20/1460

Rozlytrek

Norway

10.8.2020

EU/1/20/1484

Supemtek

Iceland

1.12.2020

EU/1/20/1484

Supemtek

Norway

24.11.2020

EU/1/20/1492

Tecartus

Norway

30.12.2020

EU/1/20/1498

TRIXEO AEROSPHERE

Norway

16.12.2020

EU/2/20/257

Tulinovet

Iceland

21.9.2020

EU/2/20/257

Tulinovet

Norway

8.12.2020

EU/1/20/1459

Veklury

Iceland

3.7.2020

EU1/20/1459

Veklury

Liechtenstein

31.8.2020

EU/1/20/1459

Veklury

Norway

3.7.2020

EU/1/20/1481

Vocabria

Norway

30.12.2020

EU/1/20/1457

Xenleta

Iceland

11.8.2020

EU/1/20/1457

Xenleta

Liechtenstein

31.8.2020

EU/1/20/1457

Xenleta

Norway

10.8.2020

EU/1/20/1444

Zabdeno

Iceland

21.7.2020

EU/1/20/1444

Zabdeno

Liechtenstein

31.8.2020

EU/1/20/1444

Zabdeno

Norway

14.7.2020

EU/1/20/1456

Zercepac

Iceland

11.8.2020

EU/1/20/1456

Zercepac

Liechtenstein

31.8.2020

EU/1/20/1456

Zercepac

Norway

10.8.2020

EU/1/20/1440

Zimbus Breezhaler

Iceland

21.7.2020

EU/1/20/1440

Zimbus Breezhaler

Liechtenstein

31.8.2020

EU/1/20/1440

Zimbus Breezhaler

Norway

13.7.2020

EU/1/20/1478

ZYNRELEF

Iceland

16.10.2020

EU/1/20/1478

Zynrelef

Norway

1.10.2020

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July – 31 December 2020:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/12/794 | ADCETRIS | Iceland | 2.10.2020 |
| EU/1/12/794 | ADCETRIS | Liechtenstein | 31.8.2020 |
| EU/1/12/794 | ADCETRIS | Norway | 14.10.2020 |
| EU/1/15/1045 | Aripiprazole Accord | Iceland | 15.10.2020 |
| EU/1/15/1045 | Aripiprazole Accord | Norway | 9.10.2020 |
| EU/1/15/1029 | Aripiprazole Sandoz | Iceland | 20.7.2020 |
| EU/1/15/1029 | Aripiprazole Sandoz | Norway | 21.7.2020 |
| EU/1/15/1063 | Armisarte | Iceland | 25.8.2020 |
| EU/1/15/1063 | Armisarte | Liechtenstein | 31.8.2020 |
| EU/1/15/1063 | Armisarte | Norway | 28.8.2020 |
| EU/1/17/1214 | Bavencio | Iceland | 10.8.2020 |
| EU/1/17/1214 | Bavencio | Norway | 25.8.2020 |
| EU/1/15/1074 | Benepali | Iceland | 7.12.2020 |
| EU/1/15/1074 | Benepali | Norway | 26.11.2020 |
| EU/1/15/1073 | Briviact | Iceland | 19.10.2020 |
| EU/1/15/1073 | Briviact | Norway | 20.10.2020 |
| EU/2/15/183 | Canigen L4 | Iceland | 26.8.2020 |
| EU/1/15/1055 | CIAMBRA | Iceland | 11.8.2020 |
| EU/1/15/1055 | Ciambra | Norway | 10.8.2020 |
| EU/1/15/1054 | Cinacalcet Mylan | Iceland | 13.10.2020 |
| EU/1/15/1054 | Cinacalcet Mylan | Norway | 1.10.2020 |
| EU/1/15/1048 | Cotellic | Iceland | 17.7.2020 |
| EU/1/15/1048 | Cotellic | Norway | 3.7.2020 |
| EU/1/15/1036 | CRESEMBA | Iceland | 24.8.2020 |
| EU/1/15/1036 | Cresemba | Liechtenstein | 31.8.2020 |
| EU/1/15/1036 | Cresemba | Norway | 28.8.2020 |
| EU/1/15/1028 | Duloxetine Zentiva | Iceland | 24.8.2020 |
| EU/1/15/1028 | Duloxetine Zentiva | Liechtenstein | 31.8.2020 |
| EU/1/15/1028 | Duloxetine Zentiva | Norway | 2.9.2020 |
| EU/1/15/1051 | Ebymect | Iceland | 3.9.2020 |
| EU/1/15/1051 | Ebymect | Norway | 7.9.2020 |
| EU/1/15/1052 | Edistride | Iceland | 15.10.2020 |
| EU/1/15/1052 | Edistride | Norway | 1.10.2020 |
| EU/1/15/1046 | Elocta | Iceland | 25.8.2020 |
| EU/1/15/1046 | Elocta | Liechtenstein | 31.8.2020 |
| EU/1/15/1058 | Entresto | Iceland | 20.7.2020 |
| EU/1/15/1058 | Entresto | Norway | 3.7.2020 |
| EU/1/15/1069 | Episalvan | Iceland | 13.10.2020 |
| EU/1/15/1069 | Episalvan | Norway | 7.10.2020 |
| EU/1/15/1065 | Eptifibatide Accord | Iceland | 15.10.2020 |
| EU/1/15/1065 | Eptifibatide Accord | Norway | 8.10.2020 |
| EU/1/19/1392 | Ervebo | Iceland | 21.9.2020 |
| EU1/19/1392 | Ervebo | Liechtenstein | 31.8.2020 |
| EU/1/19/1392 | Ervebo | Norway | 21.9.2020 |
| EU/1/15/1075 | Feraccru | Iceland | 10.12.2020 |
| EU/1/15/1075 | Feraccru | Norway | 3.12.2020 |
| EU/2/15/185 | Fortekor Plus | Iceland | 10.8.2020 |
| EU/2/15/185 | Fortekor Plus | Liechtenstein | 31.8.2020 |
| EU/2/15/185 | Fortekor Plus | Norway | 10.8.2020 |
| EU/1/15/1061 | Genvoya | Iceland | 2.10.2020 |
| EU/1/15/1061 | Genvoya | Norway | 29.9.2020 |
| EU/1/11/677 | Gilenya | Iceland | 27.11.2020 |
| EU/1/11/677 | Gilenya | Norway | 23.11.2020 |
| EU/1/15/1008 | Hetlioz | Iceland | 20.7.2020 |
| EU/1/15/1008 | Hetlioz | Norway | 13.7.2020 |
| EU/1/15/1064 | Imlygic | Iceland | 7.12.2020 |
| EU/1/15/1064 | Imlygic | Norway | 23.11.2020 |
| EU/2/15/193 | Imrestor | Iceland | 16.10.2020 |
| EU/2/15/193 | Imrestor | Norway | 9.10.2020 |
| EU/1/15/1040 | Intuniv | Iceland | 17.7.2020 |
| EU/1/15/1040 | Intuniv | Norway | 3.7.2020 |
| EU/1/11/676 | Jevtana | Norway | 22.12.2020 |
| EU/1/15/1076 | Kovaltry | Iceland | 13.10.2020 |
| EU/1/15/1076 | Kovaltry | Norway | 7.10.2020 |
| EU/1/15/1060 | Kyprolis | Iceland | 17.7.2020 |
| EU/1/15/1060 | Kyprolis | Norway | 3.7.2020 |
| EU/1/15/1067 | Lopinavir/Ritonavir Mylan | Iceland | 27.11.2020 |
| EU/1/15/1067 | Lopinavir/Ritonavir Mylan | Norway | 24.11.2020 |
| EU/1/15/1078 | Natpar | Norway | 17.8.2020 |
| EU/1/16/1094 | Ninlaro | Iceland | 7.12.2020 |
| EU/2/15/186 | Novaquin | Iceland | 24.7.2020 |
| EU/2/15/186 | Novaquin | Norway | 10.8.2020 |
| EU/1/15/1043 | Nucala | Iceland | 24.8.2020 |
| EU/1/15/1043 | Nucala | Liechtenstein | 31.8.2020 |
| EU/1/15/1043 | Nucala | Norway | 19.8.2020 |
| EU/1/15/1035 | Obizur | Iceland | 9.12.2020 |
| EU/1/15/1035 | Obizur | Norway | 26.11.2020 |
| EU/1/15/1018 | Omidria | Iceland | 10.8.2020 |
| EU/1/15/1018 | Omidria | Liechtenstein | 31.8.2020 |
| EU/1/15/1018 | Omidria | Norway | 10.8.2020 |
| EU/1/15/1070 | Oncaspar | Iceland | 7.12.2020 |
| EU/1/15/1070 | Oncaspar | Norway | 26.11.2020 |
| EU/1/18/1345 | Ondexxya | Norway | 13.8.2020 |
| EU/1/15/1059 | Orkambi | Iceland | 7.12.2020 |
| EU/1/15/1059 | Orkambi | Norway | 23.11.2020 |
| EU/1/15/1071 | Pemetrexed Accord | Iceland | 6.11.2020 |
| EU1/15/1071 | Pemetrexed Accord | Norway | 9.10.2020 |
| EU/1/15/1057 | Pemetrexed Hospira | Iceland | 14.8.2020 |
| EU/1/15/1057 | Pemetrexed Hospira | Norway | 21.8.2020 |
| EU/1/15/1038 | Pemetrexed medac | Iceland | 26.8.2020 |
| EU/1/15/1038 | Pemetrexed medac | Liechtenstein | 31.8.2020 |
| EU/1/15/1038 | Pemetrexed medac | Norway | 3.9.2020 |
| EU/1/15/1037 | Pemetrexed Sandoz | Iceland | 31.8.2020 |
| EU/1/15/1037 | Pemetrexed Sandoz | Liechtenstein | 31.8.2020 |
| EU/1/15/1037 | Pemetrexed Sandoz | Norway | 3.9.2020 |
| EU/1/19/1388 | Polivy | Norway | 17.12.2020 |
| EU/1/15/1056 | Praxbind | Iceland | 11.8.2020 |
| EU/1/15/1056 | Praxbind | Liechtenstein | 31.8.2020 |
| EU/1/15/1056 | Praxbind | Norway | 10.8.2020 |
| EU/1/15/1027 | Pregabalin Accord | Iceland | 20.7.2020 |
| EU/1/15/1027 | Pregabalin Accord | Liechtenstein | 31.8.2020 |
| EU/1/15/1027 | Pregabalin Accord | Norway | 14.7.2020 |
| EU/1/15/1011 | Pregabalin Sandoz | Iceland | 17.7.2020 |
| EU/1/15/1011 | Pregabalin Sandoz | Norway | 13.7.2020 |
| EU/1/15/1012 | Pregabalin Sandoz GmbH | Iceland | 17.7.2020 |
| EU/1/15/1012 | Pregabalin Sandoz GmbH | Norway | 13.7.2020 |
| EU/1/10/618 | Prolia | Norway | 14.8.2020 |
| EU/1/16/1090 | Rasagiline Mylan | Iceland | 9.12.2020 |
| EU/1/16/1090 | Rasagiline Mylan | Norway | 26.11.2020 |
| EU/1/15/1062 | Ravicti | Iceland | 27.8.2020 |
| EU/1/15/1062 | Ravicti | Liechtenstein | 31.8.2020 |
| EU/1/15/1062 | Ravicti | Norway | 3.9.2020 |
| EU/1/15/1020 | Raxone | Iceland | 14.8.2020 |
| EU/1/15/1020 | Raxone | Liechtenstein | 31.8.2020 |
| EU/1/15/1020 | Raxone | Norway | 19.8.2020 |
| EU/2/15/191 | Simparica | Iceland | 26.8.2020 |
| EU/2/15/191 | Simparica | Liechtenstein | 31.8.2020 |
| EU/2/15/191 | Simparica | Norway | 2.9.2020 |
| EU/1/15/1072 | Spectrila | Iceland | 15.10.2020 |
| EU/1/15/1072 | Spectrila | Norway | 29.9.2020 |
| EU/2/15/190 | Suvaxyn Circo + MH RTU | Iceland | 21.9.2020 |
| EU/2/15/190 | Suvaxyn Circo + MH RTU | Liechtenstein | 31.8.2020 |
| EU/2/15/190 | Suvaxyn Circo + MH RTU | Norway | 29.9.2020 |
| EU/1/13/902 | Translarna | Iceland | 11.8.2020 |
| EU/1/13/902 | Translarna | Norway | 20.8.2020 |
| EU/2/15/184 | UpCard | Iceland | 17.7.2020 |
| EU/2/15/184 | Upcard | Norway | 3.7.2020 |
| EU/1/15/1083 | Uptravi | Norway | 21.12.2020 |
| EU/1/15/1079 | VAXELIS | Iceland | 13.10.2020 |
| EU/1/15/1079 | Vaxelis | Norway | 15.10.2020 |
| EU/2/15/188 | Vectormune ND | Liechtenstein | 31.8.2020 |
| EU/2/15/188 | Vectormune ND | Norway | 29.7.2020 |
| EU/1/19/1385 | VITRAKVI | Iceland | 28.8.2020 |
| EU/1/19/1385 | VITRAKVI | Liechtenstein | 31.8.2020 |
| EU/1/19/1385 | VITRAKVI | Norway | 7.9.2020 |
| EU/1/11/710 | Votubia | Iceland | 10.8.2020 |
| EU/1/11/710 | Votubia | Liechtenstein | 31.8.2020 |
| EU/1/11/710 | Votubia | Norway | 10.8.2020 |
| EU/1/10/646 | VPRIV | Iceland | 10.8.2020 |
| EU/1/10/646 | VPRIV | Liechtenstein | 31.8.2020 |
| EU/1/10/646 | VPRIV | Norway | 10.8.2020 |
| EU/1/15/1042 | Zalviso | Iceland | 15.10.2020 |
| EU/1/15/1042 | Zalviso | Norway | 7.10.2020 |
| EU/1/16/1093 | Zonisamide Mylan | Norway | 15.12.2020 |
| EU/2/15/189 | Zycortal | Iceland | 27.8.2020 |
| EU/2/15/189 | Zycortal | Liechtenstein | 31.8.2020 |
| EU/2//15/189 | Zycortal | Norway | 3.9.2020 |

EU-Number

Product

Country

Date of authorisation

EU/1/12/794

ADCETRIS

Iceland

2.10.2020

EU/1/12/794

ADCETRIS

Liechtenstein

31.8.2020

EU/1/12/794

ADCETRIS

Norway

14.10.2020

EU/1/15/1045

Aripiprazole Accord

Iceland

15.10.2020

EU/1/15/1045

Aripiprazole Accord

Norway

9.10.2020

EU/1/15/1029

Aripiprazole Sandoz

Iceland

20.7.2020

EU/1/15/1029

Aripiprazole Sandoz

Norway

21.7.2020

EU/1/15/1063

Armisarte

Iceland

25.8.2020

EU/1/15/1063

Armisarte

Liechtenstein

31.8.2020

EU/1/15/1063

Armisarte

Norway

28.8.2020

EU/1/17/1214

Bavencio

Iceland

10.8.2020

EU/1/17/1214

Bavencio

Norway

25.8.2020

EU/1/15/1074

Benepali

Iceland

7.12.2020

EU/1/15/1074

Benepali

Norway

26.11.2020

EU/1/15/1073

Briviact

Iceland

19.10.2020

EU/1/15/1073

Briviact

Norway

20.10.2020

EU/2/15/183

Canigen L4

Iceland

26.8.2020

EU/1/15/1055

CIAMBRA

Iceland

11.8.2020

EU/1/15/1055

Ciambra

Norway

10.8.2020

EU/1/15/1054

Cinacalcet Mylan

Iceland

13.10.2020

EU/1/15/1054

Cinacalcet Mylan

Norway

1.10.2020

EU/1/15/1048

Cotellic

Iceland

17.7.2020

EU/1/15/1048

Cotellic

Norway

3.7.2020

EU/1/15/1036

CRESEMBA

Iceland

24.8.2020

EU/1/15/1036

Cresemba

Liechtenstein

31.8.2020

EU/1/15/1036

Cresemba

Norway

28.8.2020

EU/1/15/1028

Duloxetine Zentiva

Iceland

24.8.2020

EU/1/15/1028

Duloxetine Zentiva

Liechtenstein

31.8.2020

EU/1/15/1028

Duloxetine Zentiva

Norway

2.9.2020

EU/1/15/1051

Ebymect

Iceland

3.9.2020

EU/1/15/1051

Ebymect

Norway

7.9.2020

EU/1/15/1052

Edistride

Iceland

15.10.2020

EU/1/15/1052

Edistride

Norway

1.10.2020

EU/1/15/1046

Elocta

Iceland

25.8.2020

EU/1/15/1046

Elocta

Liechtenstein

31.8.2020

EU/1/15/1058

Entresto

Iceland

20.7.2020

EU/1/15/1058

Entresto

Norway

3.7.2020

EU/1/15/1069

Episalvan

Iceland

13.10.2020

EU/1/15/1069

Episalvan

Norway

7.10.2020

EU/1/15/1065

Eptifibatide Accord

Iceland

15.10.2020

EU/1/15/1065

Eptifibatide Accord

Norway

8.10.2020

EU/1/19/1392

Ervebo

Iceland

21.9.2020

EU1/19/1392

Ervebo

Liechtenstein

31.8.2020

EU/1/19/1392

Ervebo

Norway

21.9.2020

EU/1/15/1075

Feraccru

Iceland

10.12.2020

EU/1/15/1075

Feraccru

Norway

3.12.2020

EU/2/15/185

Fortekor Plus

Iceland

10.8.2020

EU/2/15/185

Fortekor Plus

Liechtenstein

31.8.2020

EU/2/15/185

Fortekor Plus

Norway

10.8.2020

EU/1/15/1061

Genvoya

Iceland

2.10.2020

EU/1/15/1061

Genvoya

Norway

29.9.2020

EU/1/11/677

Gilenya

Iceland

27.11.2020

EU/1/11/677

Gilenya

Norway

23.11.2020

EU/1/15/1008

Hetlioz

Iceland

20.7.2020

EU/1/15/1008

Hetlioz

Norway

13.7.2020

EU/1/15/1064

Imlygic

Iceland

7.12.2020

EU/1/15/1064

Imlygic

Norway

23.11.2020

EU/2/15/193

Imrestor

Iceland

16.10.2020

EU/2/15/193

Imrestor

Norway

9.10.2020

EU/1/15/1040

Intuniv

Iceland

17.7.2020

EU/1/15/1040

Intuniv

Norway

3.7.2020

EU/1/11/676

Jevtana

Norway

22.12.2020

EU/1/15/1076

Kovaltry

Iceland

13.10.2020

EU/1/15/1076

Kovaltry

Norway

7.10.2020

EU/1/15/1060

Kyprolis

Iceland

17.7.2020

EU/1/15/1060

Kyprolis

Norway

3.7.2020

EU/1/15/1067

Lopinavir/Ritonavir Mylan

Iceland

27.11.2020

EU/1/15/1067

Lopinavir/Ritonavir Mylan

Norway

24.11.2020

EU/1/15/1078

Natpar

Norway

17.8.2020

EU/1/16/1094

Ninlaro

Iceland

7.12.2020

EU/2/15/186

Novaquin

Iceland

24.7.2020

EU/2/15/186

Novaquin

Norway

10.8.2020

EU/1/15/1043

Nucala

Iceland

24.8.2020

EU/1/15/1043

Nucala

Liechtenstein

31.8.2020

EU/1/15/1043

Nucala

Norway

19.8.2020

EU/1/15/1035

Obizur

Iceland

9.12.2020

EU/1/15/1035

Obizur

Norway

26.11.2020

EU/1/15/1018

Omidria

Iceland

10.8.2020

EU/1/15/1018

Omidria

Liechtenstein

31.8.2020

EU/1/15/1018

Omidria

Norway

10.8.2020

EU/1/15/1070

Oncaspar

Iceland

7.12.2020

EU/1/15/1070

Oncaspar

Norway

26.11.2020

EU/1/18/1345

Ondexxya

Norway

13.8.2020

EU/1/15/1059

Orkambi

Iceland

7.12.2020

EU/1/15/1059

Orkambi

Norway

23.11.2020

EU/1/15/1071

Pemetrexed Accord

Iceland

6.11.2020

EU1/15/1071

Pemetrexed Accord

Norway

9.10.2020

EU/1/15/1057

Pemetrexed Hospira

Iceland

14.8.2020

EU/1/15/1057

Pemetrexed Hospira

Norway

21.8.2020

EU/1/15/1038

Pemetrexed medac

Iceland

26.8.2020

EU/1/15/1038

Pemetrexed medac

Liechtenstein

31.8.2020

EU/1/15/1038

Pemetrexed medac

Norway

3.9.2020

EU/1/15/1037

Pemetrexed Sandoz

Iceland

31.8.2020

EU/1/15/1037

Pemetrexed Sandoz

Liechtenstein

31.8.2020

EU/1/15/1037

Pemetrexed Sandoz

Norway

3.9.2020

EU/1/19/1388

Polivy

Norway

17.12.2020

EU/1/15/1056

Praxbind

Iceland

11.8.2020

EU/1/15/1056

Praxbind

Liechtenstein

31.8.2020

EU/1/15/1056

Praxbind

Norway

10.8.2020

EU/1/15/1027

Pregabalin Accord

Iceland

20.7.2020

EU/1/15/1027

Pregabalin Accord

Liechtenstein

31.8.2020

EU/1/15/1027

Pregabalin Accord

Norway

14.7.2020

EU/1/15/1011

Pregabalin Sandoz

Iceland

17.7.2020

EU/1/15/1011

Pregabalin Sandoz

Norway

13.7.2020

EU/1/15/1012

Pregabalin Sandoz GmbH

Iceland

17.7.2020

EU/1/15/1012

Pregabalin Sandoz GmbH

Norway

13.7.2020

EU/1/10/618

Prolia

Norway

14.8.2020

EU/1/16/1090

Rasagiline Mylan

Iceland

9.12.2020

EU/1/16/1090

Rasagiline Mylan

Norway

26.11.2020

EU/1/15/1062

Ravicti

Iceland

27.8.2020

EU/1/15/1062

Ravicti

Liechtenstein

31.8.2020

EU/1/15/1062

Ravicti

Norway

3.9.2020

EU/1/15/1020

Raxone

Iceland

14.8.2020

EU/1/15/1020

Raxone

Liechtenstein

31.8.2020

EU/1/15/1020

Raxone

Norway

19.8.2020

EU/2/15/191

Simparica

Iceland

26.8.2020

EU/2/15/191

Simparica

Liechtenstein

31.8.2020

EU/2/15/191

Simparica

Norway

2.9.2020

EU/1/15/1072

Spectrila

Iceland

15.10.2020

EU/1/15/1072

Spectrila

Norway

29.9.2020

EU/2/15/190

Suvaxyn Circo + MH RTU

Iceland

21.9.2020

EU/2/15/190

Suvaxyn Circo + MH RTU

Liechtenstein

31.8.2020

EU/2/15/190

Suvaxyn Circo + MH RTU

Norway

29.9.2020

EU/1/13/902

Translarna

Iceland

11.8.2020

EU/1/13/902

Translarna

Norway

20.8.2020

EU/2/15/184

UpCard

Iceland

17.7.2020

EU/2/15/184

Upcard

Norway

3.7.2020

EU/1/15/1083

Uptravi

Norway

21.12.2020

EU/1/15/1079

VAXELIS

Iceland

13.10.2020

EU/1/15/1079

Vaxelis

Norway

15.10.2020

EU/2/15/188

Vectormune ND

Liechtenstein

31.8.2020

EU/2/15/188

Vectormune ND

Norway

29.7.2020

EU/1/19/1385

VITRAKVI

Iceland

28.8.2020

EU/1/19/1385

VITRAKVI

Liechtenstein

31.8.2020

EU/1/19/1385

VITRAKVI

Norway

7.9.2020

EU/1/11/710

Votubia

Iceland

10.8.2020

EU/1/11/710

Votubia

Liechtenstein

31.8.2020

EU/1/11/710

Votubia

Norway

10.8.2020

EU/1/10/646

VPRIV

Iceland

10.8.2020

EU/1/10/646

VPRIV

Liechtenstein

31.8.2020

EU/1/10/646

VPRIV

Norway

10.8.2020

EU/1/15/1042

Zalviso

Iceland

15.10.2020

EU/1/15/1042

Zalviso

Norway

7.10.2020

EU/1/16/1093

Zonisamide Mylan

Norway

15.12.2020

EU/2/15/189

Zycortal

Iceland

27.8.2020

EU/2/15/189

Zycortal

Liechtenstein

31.8.2020

EU/2//15/189

Zycortal

Norway

3.9.2020

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July – 31 December 2020:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/14/980/008-011 | Cosentyx | Iceland | 9.12.2020 |
| EU/1/14/980/008-011 | Cosentyx | Norway | 30.11.2020 |
| EU/1/16/1116/002 | Epclusa | Iceland | 31.8.2020 |
| EU/1/16/1116/002 | Epclusa | Norway | 3.9.2020 |
| EU/1/14/958/003-005 | Harvoni | Iceland | 21.7.2020 |
| EU/1/14/958 | Harvoni | Norway | 14.7.2020 |
| EU/1/16/1095/009 | IDELVION | Iceland | 27.8.2020 |
| EU/1/16/1095/009 | IDELVION | Norway | 3.9.2020 |
| EU/1/12/782/007 | Kalydeco | Iceland | 9.12.2020 |
| EU/1/12/782 | Kalydeco | Norway | 25.11.2020 |
| EU/1/15/1071/004-007 | Pemetrexed Accord | Iceland | 8.12.2020 |
| EU/1/15/1071 | Pemetrexed Accord | Norway | 16.11.2020 |
| EU/1/15/1057/004-006 | Pemetrexed Hospira | Iceland | 15.10.2020 |
| EU/1/15/1057 | Pemetrexed Hospira | Norway | 30.9.2020 |
| EU/1/14/934 | Plegridy | Norway | 14.12.2020 |
| EU/1/15/1031/019-020 | Praluent | Iceland | 24.8.2020 |
| EU/1/13/894/003-005 | Sovaldi | Iceland | 20.7.2020 |
| EU/1/13/894 | Sovaldi | Norway | 3.7.2020 |
| EU/1/06/359/007-018 | Suboxone | Iceland | 21.7.2020 |
| EU/1/06/359/007-018 | Suboxone | Norway | 17.7.2020 |
| EU/1/18/1306/002 | Symkevi | Iceland | 9.12.2020 |
| EU/1/18/1306 | Symkevi | Norway | 25.11.2020 |
| EU/1/14/956/011-016 | Trulicity | Iceland | 9.12.2020 |
| EU/1/14/956/011-016 | Trulicity | Norway | 2.12.2020 |
| EU/1/19/1371/002-003 | Ultomiris | Iceland | 3.12.2020 |
| EU/1/19/1371/002-003 | Ultomiris | Norway | 25.11.2020 |
| EU/1/14/943/005 | Velphoro | Iceland | 27.11.2020 |
| EU/1/14/943/005 | Velphoro | Norway | 23.11.2020 |

EU-Number

Product

Country

Date of authorisation

EU/1/14/980/008-011

Cosentyx

Iceland

9.12.2020

EU/1/14/980/008-011

Cosentyx

Norway

30.11.2020

EU/1/16/1116/002

Epclusa

Iceland

31.8.2020

EU/1/16/1116/002

Epclusa

Norway

3.9.2020

EU/1/14/958/003-005

Harvoni

Iceland

21.7.2020

EU/1/14/958

Harvoni

Norway

14.7.2020

EU/1/16/1095/009

IDELVION

Iceland

27.8.2020

EU/1/16/1095/009

IDELVION

Norway

3.9.2020

EU/1/12/782/007

Kalydeco

Iceland

9.12.2020

EU/1/12/782

Kalydeco

Norway

25.11.2020

EU/1/15/1071/004-007

Pemetrexed Accord

Iceland

8.12.2020

EU/1/15/1071

Pemetrexed Accord

Norway

16.11.2020

EU/1/15/1057/004-006

Pemetrexed Hospira

Iceland

15.10.2020

EU/1/15/1057

Pemetrexed Hospira

Norway

30.9.2020

EU/1/14/934

Plegridy

Norway

14.12.2020

EU/1/15/1031/019-020

Praluent

Iceland

24.8.2020

EU/1/13/894/003-005

Sovaldi

Iceland

20.7.2020

EU/1/13/894

Sovaldi

Norway

3.7.2020

EU/1/06/359/007-018

Suboxone

Iceland

21.7.2020

EU/1/06/359/007-018

Suboxone

Norway

17.7.2020

EU/1/18/1306/002

Symkevi

Iceland

9.12.2020

EU/1/18/1306

Symkevi

Norway

25.11.2020

EU/1/14/956/011-016

Trulicity

Iceland

9.12.2020

EU/1/14/956/011-016

Trulicity

Norway

2.12.2020

EU/1/19/1371/002-003

Ultomiris

Iceland

3.12.2020

EU/1/19/1371/002-003

Ultomiris

Norway

25.11.2020

EU/1/14/943/005

Velphoro

Iceland

27.11.2020

EU/1/14/943/005

Velphoro

Norway

23.11.2020

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July – 31 December 2020:

| EU-Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/18/1269 | Alpivab | Iceland | 9.12.2020 |
| EU/1/18/1269 | Alpivab | Norway | 10.12.2020 |
| EU/1/10/623 | Clopidogrel/Acetylsalicylic acid Zentiva | Iceland | 14.8.2020 |
| EU/1/18/1300 | Duzallo | Iceland | 11.8.2020 |
| EU/1/18/1300 | Duzallo | Norway | 10.9.2020 |
| EU/1/13/895 | Kolbam | Iceland | 20.7.2020 |
| EU/1/13/895 | Kolbam | Norway | 11.8.2020 |
| EU/1/00/149 | Panretin | Iceland | 13.11.2020 |
| EU/1/19/1401 | Qtrilmet | Iceland | 24.8.2020 |
| EU/1/19/1401 | Qtrilmet | Liechtenstein | 31.8.2020 |
| EU/1/19/1401 | Qtrilmet | Norway | 8.10.2020 |
| EU/1/20/1463 | Qutavina | Iceland | 10.12.2020 |
| EU/1/20/1463 | Qutavina | Norway | 18.12.2020 |
| EU/1/10/634 | Ribavirin Mylan | Iceland | 5.11.2020 |
| EU/1/10/634 | Ribavirin Mylan | Norway | 5.11.2020 |
| EU/1/07/388 | Sebivo | Iceland | 27.11.2020 |
| EU/1/07/388 | Sebivo | Norway | 23.11.2020 |
| EU/2/09/099 | Suvaxyn PCV | Iceland | 24.7.2020 |
| EU/1/12/752 | Vepacel | Iceland | 14.10.2020 |
| EU/1/12/752 | Vepacel | Norway | 8.10.2020 |
| EU/1/96/009 | Zerit | Iceland | 17.7.2020 |
| EU/1/96/009 | Zerit | Norway | 8.7.2020 |
| EU/2/09/105 | Zulvac 8 Bovis | Iceland | 12.11.2020 |
| EU/2/09/105 | Zulvac 8 Bovis | Norway | 11.11.2020 |
| EU/1/15/1080 | Zurampic | Iceland | 12.8.2020 |
| EU/1/15/1080 | Zurampic | Liechtenstein | 31.8.2020 |
| EU/1/15/1080 | Zurampic | Norway | 10.9.2020 |

EU-Number

Product

Country

Date of withdrawal

EU/1/18/1269

Alpivab

Iceland

9.12.2020

EU/1/18/1269

Alpivab

Norway

10.12.2020

EU/1/10/623

Clopidogrel/Acetylsalicylic acid Zentiva

Iceland

14.8.2020

EU/1/18/1300

Duzallo

Iceland

11.8.2020

EU/1/18/1300

Duzallo

Norway

10.9.2020

EU/1/13/895

Kolbam

Iceland

20.7.2020

EU/1/13/895

Kolbam

Norway

11.8.2020

EU/1/00/149

Panretin

Iceland

13.11.2020

EU/1/19/1401

Qtrilmet

Iceland

24.8.2020

EU/1/19/1401

Qtrilmet

Liechtenstein

31.8.2020

EU/1/19/1401

Qtrilmet

Norway

8.10.2020

EU/1/20/1463

Qutavina

Iceland

10.12.2020

EU/1/20/1463

Qutavina

Norway

18.12.2020

EU/1/10/634

Ribavirin Mylan

Iceland

5.11.2020

EU/1/10/634

Ribavirin Mylan

Norway

5.11.2020

EU/1/07/388

Sebivo

Iceland

27.11.2020

EU/1/07/388

Sebivo

Norway

23.11.2020

EU/2/09/099

Suvaxyn PCV

Iceland

24.7.2020

EU/1/12/752

Vepacel

Iceland

14.10.2020

EU/1/12/752

Vepacel

Norway

8.10.2020

EU/1/96/009

Zerit

Iceland

17.7.2020

EU/1/96/009

Zerit

Norway

8.7.2020

EU/2/09/105

Zulvac 8 Bovis

Iceland

12.11.2020

EU/2/09/105

Zulvac 8 Bovis

Norway

11.11.2020

EU/1/15/1080

Zurampic

Iceland

12.8.2020

EU/1/15/1080

Zurampic

Liechtenstein

31.8.2020

EU/1/15/1080

Zurampic

Norway

10.9.2020

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July – 31 December 2020:

| EU-Number | Product | Country | Date of suspension |
| --- | --- | --- | --- |
| EU/1/12/750 | Esmya | Iceland | 26.8.2020 |
| EU/1/18/1309 | Ulipristal Acetate Gedeon Richter 5 | Iceland | 26.8.2020 |

EU-Number

Product

Country

Date of suspension

EU/1/12/750

Esmya

Iceland

26.8.2020

EU/1/18/1309

Ulipristal Acetate Gedeon Richter 5

Iceland

26.8.2020

---